CellSight Technologies
PrivateLast Round
SBIR Phase
II
Sep 16, 2022
Total Funding Raised
$2.19M
Company Overview
CellSight Technologies is a biotechnology company that develops PET imaging tracers for diagnostic imaging in the immunotherapy field.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellSight Technologies Comparables
Compare CellSight Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoSite Bio | 88% | |
| imuveo | 83% | |
| Telix Pharmaceuticals | 81% | |
CellSight Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SBIR Phase II | Sep 16, 2022 | ||||
| Corporate Funding | Nov 8, 2017 |
CellSight Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | SBIR Phase II, SBIR Phase I |
| Boehringer Ingelheim | Corporate Funding |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2025
Monthly visitors increased 45% MoM, reaching 1.1K.
- Sep 16, 2022
Raised $2M with the National Cancer Institute as lead investor.
CellSight Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellSight Technologies's valuation, stock price, and market status.